Skip to main content

Advertisement

Log in

Large granular lymphocyte leukemia

  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

Clonal diseases of large granular lymphocytes (LGLs) represent a spectrum of clinically rare lymphoproliferative malignancies arising from either mature T-cell (CD3+) or natural killer (NK)-cell (CD3) lineages. The clinical behavior of these disorders ranges from indolent to very aggressive. Patients with symptomatic indolent T-cell or NK-cell LGL leukemia are usually treated with immunosuppressive therapies; in contrast, aggressive T-cell or NK-cell LGL leukemias require intensive chemotherapy regimens. Novel targeted therapies are currently being tested in clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Loughran TP Jr: Clonal diseases of large granular lymphocytes. Blood 1993, 82:1–14.

    PubMed  Google Scholar 

  2. Loughran TP Jr, Kadin ME, Starkebaum G, et al.: Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 1985, 102:169–175.

    PubMed  Google Scholar 

  3. Chan WC, Catovsky D, Foucar K, et al.: T-cell large granular lymphocyte leukaemia. World Health Organization Classification of Tumors. In Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. Edited by Jaffe E, Harris N, Stein H, Vardiman J. Lyon, France: IARC Press; 2001:197–198.

    Google Scholar 

  4. Sokol L, Loughran TP Jr: Large granular lymphocyte leukemia. Oncologist 2006, 11:263–273.

    Article  PubMed  CAS  Google Scholar 

  5. Loughran TP Jr, Hadlock KG, Perzova R, et al.: Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998, 101:318–324.

    Article  PubMed  CAS  Google Scholar 

  6. Lamy T, Liu TH, Landowski TH, et al.: Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998, 92:4771–4777.

    PubMed  CAS  Google Scholar 

  7. Schade AE, Powers JJ, Wlodarski MW, et al.: Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 2006, 107:4834–4840.

    Article  PubMed  CAS  Google Scholar 

  8. Epling-Burnette PK, Bai F, Wei S, et al.: ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 2004, 23:9220–9229.

    PubMed  CAS  Google Scholar 

  9. Lamy T, Loughran TP: Large granular lymphocyte leukemia. Cancer Control 1998, 5:25–33.

    PubMed  Google Scholar 

  10. Berliner N, Horwitz M, Loughran TP: Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program 2004, 63–79.

  11. Lacy MQ, Kurtin PJ, Tefferi A: Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996, 87:3000–3006.

    PubMed  CAS  Google Scholar 

  12. Starkebaum G, Loughran TP Jr, Gaur LK, et al.: Immunogenetic similarities between patients with Felty’s syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997, 40:624–626.

    Article  PubMed  CAS  Google Scholar 

  13. Karadimitris A, Li K, Notaro R, et al.: Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. Br J Haematol 2001, 115:1010–1014.

    Article  PubMed  CAS  Google Scholar 

  14. Saunthararajah Y, Molldrem JL, Rivera M, et al.: Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001, 112:195–200.

    Article  PubMed  CAS  Google Scholar 

  15. Tsukamoto N, Morita K, Maehara T, et al.: Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 1993, 83:589–594.

    PubMed  CAS  Google Scholar 

  16. Mongkonsritragoon W, Letendre L, Li CY: Multiple lymphoid nodules in bone marrow have the same clonality as underlying myelodysplastic syndrome recognized with fluorescent in situ hybridization technique. Am J Hematol 1998, 59:252–257.

    Article  PubMed  CAS  Google Scholar 

  17. Semenzato G, Zambello R, Starkebaum G, et al.: The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997, 89:256–260.

    PubMed  CAS  Google Scholar 

  18. Wong KF, Chan JC, Liu HS, et al.: Chromosomal abnormalities in T-cell large granular lymphocyte leukaemia: report of two cases and review of the literature. Br J Haematol 2002, 116:598–600.

    Article  PubMed  CAS  Google Scholar 

  19. Nowakowski GS, Morice WG, Zent CS, et al.: Initial presentation and prognostic factors in 286 patients with t-cell large granular lymphocyte leukemia [abstract]. Blood (ASH Annual Meeting Abstracts) 2006, 108: Abstract 300.

  20. Alekshun TJ, Sokol L: Diseases of large granular lymphocytes. Cancer Control 2007, 14:141–150.

    PubMed  Google Scholar 

  21. Loughran TP Jr, Kidd PG, Starkebaum G: Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994, 84:2164–2170.

    PubMed  Google Scholar 

  22. Osuji N, Matutes E, Tjonnfjord G, et al.: T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer 2006, 107:570–578.

    Article  PubMed  Google Scholar 

  23. Sood R, Stewart CC, Aplan PD, et al.: Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998, 91:3372–3378.

    PubMed  CAS  Google Scholar 

  24. Lamy T, LePrise PY, Amiot L, et al.: Response to granulocyte-macrophage colony-stimulating factor (GM-CSF) but not to G-CSF in a case of agranulocytosis associated with large granular lymphocyte (LGL) leukemia. Blood 1995, 85:3352–3353.

    PubMed  CAS  Google Scholar 

  25. Witzig TE, Weitz JJ, Lundberg JH, et al.: Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues. Leuk Lymphoma 1994, 14:137–139.

    PubMed  CAS  Google Scholar 

  26. Rosenblum MD, LaBelle JL, Chang CC, et al.: Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia. Blood 2004, 103:1969–1971.

    Article  PubMed  CAS  Google Scholar 

  27. Aprile JA, Russo M, Pepe MS, et al.: Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes. Blood 1991, 78:1282–1285.

    PubMed  CAS  Google Scholar 

  28. Alekshun T, Tao J, Sokol L: Aggressive T-cell large granular lymphocyte leukemia. A case report and review of the literature. Am J Hematol 2007, 82:481–485.

    Article  PubMed  Google Scholar 

  29. Gentile TC, Uner AH, Hutchison RE, et al.: CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 1994, 84:2315–2321.

    PubMed  CAS  Google Scholar 

  30. Macon WR, Williams ME, Greer JP, et al.: Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996, 87:1474–1483.

    PubMed  CAS  Google Scholar 

  31. Passetto FR, Pinto SB, Garcia AB, et al.: Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers. Acta Haematol 2000, 104:110–114.

    Article  Google Scholar 

  32. Tordjman R, Macintyre E, Emile JF, et al.: Aggressive acute CD3+, CD56-T cell large granular lymphocyte leukemia with two stages of maturation arrest. Leukemia 1996, 10:1514–1519.

    PubMed  CAS  Google Scholar 

  33. Matutes E, Wotherspoon AC, Parker NE, et al.: Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma. Br J Haematol 2001, 115:801–806.

    Article  PubMed  CAS  Google Scholar 

  34. Zambello R, Loughran TP Jr, Trentin L, et al.: Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. Leukemia 1995, 9:1207–1211.

    PubMed  CAS  Google Scholar 

  35. Tefferi A, Li CY, Witzig TE, et al.: Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994, 84:2721–2725.

    PubMed  CAS  Google Scholar 

  36. Zambello R, Semenzato G: Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes. Semin Hematol 2003, 40:201–212.

    Article  PubMed  CAS  Google Scholar 

  37. Chan JKC, Wong KF, Jaffe ES, et al.: Aggressive NK-cell leukemia. World Health Organization Classification of Tumors. In Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. Edited by Jaffe E, Harris N, Stein H, Vardiman J. Lyon, France: IARC Press; 2001:198–200.

    Google Scholar 

  38. Wong KF, Zhang YM, Chan JK: Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia—Is there a consistent pattern? Leuk Lymphoma 1999, 34:241–250.

    PubMed  CAS  Google Scholar 

  39. Okamura T, Kishimoto T, Inoue M, et al.: Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant 2003, 31:105–111.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas P. Loughran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sokol, L., Loughran, T.P. Large granular lymphocyte leukemia. Curr Hematol Malig Rep 2, 278–282 (2007). https://doi.org/10.1007/s11899-007-0038-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-007-0038-7

Keywords

Navigation